Table 2.
Dose level | Cixutumumab weekly dose (mg/kg) | Prior estimate for DLT (%) | Patients treated | Patients with DLT (s) | Posterior estimate for DLT (%) | 95% Bayesian credible interval (%) |
---|---|---|---|---|---|---|
A | 1 | 10 | 4 | 0 | 4.5 | 1.0–14.1 |
B | 3 | 13 | 13 | 1 | 6.2 | 1.6–17.8 |
C | 6 | 18 | 12 | 1 | 9.4 | 2.7–23.6 |